Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.23 AUD | -4.17% | -8.00% | -4.17% |
06-11 | Artrya Signs Five-Year Agreement with Cone Health in US; Shares Decline 4% | MT |
06-07 | Artrya Submits Second Q-Submission to Finalize FDA Application | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.28M 25.89M 1.36B |
---|---|---|---|---|---|
Net income 2022 | -17M -25.47M -1.34B | Net income 2023 | -11M -16.48M -867M | EV / Sales 2022 | - |
Net cash position 2022 | 34.19M 51.23M 2.69B | Net cash position 2023 | 19.19M 28.76M 1.51B | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.51
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.29% |
1 day | -4.17% | ||
1 week | -8.00% | ||
Current month | -13.21% | ||
1 month | -8.00% | ||
3 months | -17.86% | ||
6 months | +15.00% | ||
Current year | -4.17% |
Managers | Title | Age | Since |
---|---|---|---|
Mathew Regan
CEO | Chief Executive Officer | - | 26/03/23 |
Mark Wainwright
DFI | Director of Finance/CFO | - | 31/08/21 |
Jacob Agris
CTO | Chief Tech/Sci/R&D Officer | - | 19/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacque Sokolov
BRD | Director/Board Member | 69 | 31/07/22 |
Chairman | 70 | 31/01/21 | |
Catherine Hill
BRD | Director/Board Member | 65 | 21/02/23 |
Date | Price | Change | Volume |
---|---|---|---|
20/06/24 | 0.23 | -4.17% | 55 832 |
19/06/24 | 0.24 | 0.00% | 43,300 |
18/06/24 | 0.24 | 0.00% | 112,416 |
17/06/24 | 0.24 | -4.00% | 3,500 |
13/06/24 | 0.25 | 0.00% | 3,078 |
Delayed Quote Australian S.E., June 20, 2024 at 06:57 am
More quotes1st Jan change | Capi. | |
---|---|---|
-4.17% | 12.6M | |
-16.71% | 8.53B | |
+67.76% | 4.31B | |
+4.70% | 2.67B | |
-2.80% | 2.62B | |
-53.41% | 1.87B | |
-19.59% | 1.66B | |
-21.62% | 1.41B | |
+16.16% | 1.2B | |
-46.45% | 1.09B |
- Stock Market
- Equities
- AYA Stock